Evaluating night splinting after needle fasciotomy for Dupuytren's contracture
Official title: Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture - a Randomised Controlled Multicenter Trial
Run by Uppsala University · NCT05300893 · Data updated 2026-11-12
This study is testing if wearing a night splint after a needle procedure for Dupuytren's contracture can help prevent the condition from coming back compared to just physical therapy alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 154 (estimated) |
| Sponsor | Uppsala University Academic / other |
| Locations | 3 sites (Falun, Dalarna County and 2 other locations) |
| Status | Recruiting |
| Started | September 14, 2022 |
| Main results expected | January 2026 |
| Study ends | January 2027 |
| Registry record updated | May 31, 2024 |
| Trial ID | NCT05300893 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with specific Dupuytren's contracture characteristics as defined by the Tubiana classification.
✕Probably not a fit
Patients with advanced Dupuytren's contracture or those who have previously undergone treatment for the same digit may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of night splinting following percutaneous needle fasciotomy (PNF) in patients with Dupuytren's contracture. Patients will be randomized into two groups: one receiving standard physical therapy and night splinting, and the other receiving physical therapy without splinting. The primary goal is to determine if night splinting reduces the recurrence rate of Dupuytren's contracture after PNF. This approach aims to provide insights into optimizing post-treatment care for this condition.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies that reduce the recurrence of Dupuytren's contracture after treatment.
How similar studies have gone: While the effectiveness of night splinting is debated, this study aims to provide new insights, as similar approaches have not been extensively validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older, * Palpable Dupuytren strand with passive extension deficit according to stadium 1 and 2 of the classification of Tubiana in one or two fingers excluding the thumb, defined as at least 30 degrees in the MCP joint and/or at least 20 degrees in the PIP joint and a maximum of 75 degrees in the MCP or PIP joint Exclusion Criteria: * Multiple, invasive or wide strands in the palm, * Skin irritation, * Strand localization in the digit only, * Digital nerve injury, * Any former treatment for Dupuytren's contracture in the same digit, * Thumb contracture, * Stadium 3 and 4 according to the classification of Tubiana
Where it's running
-
Falu Lasarett
Falun, Dalarna County, Sweden Recruiting -
Akademiska Sjukhuset
Uppsala, Uppsala County, Sweden Recruiting -
Universitetssjukhuset Örebro
Örebro, Örebro County, Sweden Recruiting
Study contacts
- Principal investigator: Stephan Wilbrand, MD, PhD — Uppsala University
- Study coordinator: Daniel Muder, MD
- Email: daniel.muder@surgsci.uu.se
- Phone: 0046-23-490000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treatment options for Dupuytren's contracture
This study is testing whether adding a corticosteroid injection to a needle treatment helps people with Dupuytren's contracture move their fingers better.
-
Evaluating post-surgery radiation treatment for Dupuytren's disease
This study is testing whether adding radiation treatment after surgery for Dupuytren's disease can help improve hand function and reduce symptoms for patients.
-
CNT201 collagenase injection for Dupuytren’s: safety and signals of efficacy in adults
A randomized, placebo-controlled study will test CNT201 injections to see if they are safe and help improve finger contractures in adults with Dupuytren’s disease.
-
Evaluating a new ultrasound-guided technique for Dupuytren's contracture
This study is testing a new ultrasound-guided procedure to see if it can safely improve hand function for people with Dupuytren's contracture while causing fewer problems than traditional surgery.
-
Using radiation therapy to prevent Dupuytren's contracture recurrence after treatment
This study is testing if targeted radiation therapy can help prevent Dupuytren's contracture from coming back after treatment in people aged 45 and older.
-
Treatment for early Dupuytren's disease using vitamin E cream
This study is testing if using vitamin E cream can help people with early Dupuytren's disease stop their fingers from getting worse.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.